Scrivere la risposta quihttp://www.neurenpharma.com/IRM/PDF/1558/TrofinetidesuccessfulinPhase2trialinFragileX
Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-10
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.15 |
Change
0.875(7.13%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.36 | $12.79 | $6.825M | 523.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 415 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 756 | 15 |
View Market Depth
| Last trade - 14.59pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |